CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...